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SUMMARY : To know a difference in the immune responses between the lung 
and the kindly allo-transplantation, the humoral and cell bound antibody levels were 
compared by means of cytotoxic assay (CA) and Immune hemoagglutination (IA) 
test in dogs. 
1) The humoral antibody levels were increased five to 10 days prior to appearance 
   of rejection following lung transplantation in spite of maintaining relatively low 
   levels in the course although it was different from kidney one. 
2) On the other hand, the cell bound antibody levels were not increased in accord-
   ance with the rejection response at lung transplantation. Meanwhile, renal trans-
   plantation made the cell antibody levels higher with time in the humoral anti-
   body levels, although cell-bound antibody levels were increased on day five to 
   seven with a seven day maximum, thereafter gradually decreased to some extent.
   It is of considerable interest that a high humornal antibody levels had a close re-
   lation to death. 
3) The administration of the antilymphocyte serum (ALS) was effective in suppress-
   ing the immune response showing the low humoral antibody levels and improv-
   ed survival period. 
4) Skin transplantation prior to lung or kidney transplantation kept high antibody 
   titers on and after day four lung transplantation and on day seven to 10 at kid-
   ney. Conclusion was drawn from this study that skin and lung or kidney have 
   the common cross reacting antigenicity to organ transplantation, in particular, 
   the lung has a strong cross reacting antigenicity to the skin rather than the kidney.
       INTRODUCTION 
 It is well known that the lung as well as the 
spleen has the strong antigenicity concerning 
organ transplantation as reported by DEODH u 1) 
and STWART 2) and these have shown great rejec-
tion response when applied for transplantation. 
 TERASAKI3 ) reported that the humoral anti-
body produced by skin allotransplantation sele-
ctively attacks the lymphocyte of a donor. On 
the other hand, there are many reports concern-
ing humoral antibody which plays a key role in
activating the immune state, related to organ 
transplantation. Needless to say, cellular im-
munity also mainly causes the transplanted or-
gans to be rejected. 
 The aim of this study is to clarify a differ-
ence in the immunologic response with regard 
to rejection response between lung and kidney 
transplantation and also a Gloss reacting anti-
genicity to a donor organ among the skin, the 
kidney and the lung. Antilymphocytic serum 
(ALS) was verified for prevention from rejec-
tion response to a donor lung.
    MATERIAL AND METHOD 
 Mongrel dogs weighing from 10 to 20kg were 
used for the study. A pair of donor and reci-
pient was selected in almost the same sized 
dogs, anesthetized with 25 mg/kgg of sodium 
pentobarbital, intubated with a cuffed endotra-
cheal tube and ventilated with room air using 
a volume respirator (Harvard). 
Lung, kidney & skin transplantation 
  Left lung homotransplantation was made 
with conventional manner as described by many 
authors. 
  A donor dog was taken care and survived to 
provide the target cells from the mesenterial 
nodes later. After perfusing a donor kidney us-
ing a perfusate (500m1 of 10% LWD with Sa-
line containing ig of 10% HC1-procaine, 10mg 
of heparine with 100cm of gravity during a 20 
to 40 min period of time). A kidney was trans-
planted in the femoral region by vascular ana-
stomoses to the femoral artery and vein in a 
recipient as well as by ureterocutaneous fistula 
on the back to check out the daily urine output. 
  On the other hand, skin transplantation was 
made to the lateral chest wall using 5 X 5 cm skin 
graft. The infected and bleeding skin grafts were 
excluded from this study. 
  At an interval of seven and 10 days, skin 
transplantations were repeated and then allo-
lung or renal transplantation was attempted. 
Thirty mg /kg of penicillin G were used for 
prevention from postoperative infection. 
Preparation of antilymphocyte serum 
  The pulmonary hilar and mesenterial lymph 
nodes were aseptically taken in 199 Medium, 
cut into pieces by scissors, f iltrated with glass 
wool and centrifuged at 800 rm for 10 min, dis-
carded the suspension and rinsed with saline. 
These were repeated three times and adjusted 
to 50 X 106/mm of lymphocytes, Equal Freund 
adjuvant was added. 0.2m1 were subcutaneous-
ly injected. 
  At the second time, the lymphocytes with 
the same as above procedure without adding 
Freund' adjuvant were used one week later. 
Three times or more, this injection was re-
peated until reaching the level of 2`° of agglu-
tination titer of the leucocyte. 
 Antidog rabbit serum was taken from the 
femoral artery and kept at room temperature 
for two hours. The remained blood was centri-
fuged and warmed at 56°C for 30 min to make 
it inactive and stored at -20°C in freezer. 
 0.5 to 1.Oml ALS were injected to a recipient 
five and seven day prior to and three times a 
week after transplantation. 
Detection of humoral and cell-bound antibody 
following transplantation 
  The levels of the humoral and cell-bound 
antibody following lung, kidney and skin trans-
plantation were compared by using the meth-
ods of cytotoxic assay (CA)4) and Immunoadhe-
rent (IA) titer 5)- 7) 
. 1) CA 
 The damaged cells were identified by trypan-
blue staining and represented as a rate of total 
cells. 
a ) target cell : the nodes in the pulmonary 
hilum and the mesenterium of a donor were 
taken, kept in 199 Medium for 30 min, filtrated 
with glass fiber, cooled and dicarded the super-
natant. Ten ml of 199 Medium were added and 
centrifuged three times, rinsed the lymphocyted 
to exclude dead cells and cell debris. After con-
firming it by trypan-blue staining, the cells 
were adjusted to 2 X 106 or 4 X 10°/ml. 
b) Dilution of antiserum and lymphocyte sus-
pension : Antiserum was diluted with KGVB 
to 1X, 2X, 4X, 8X, 16X, 32X and 64X res-
pectively. Sensitized cells into 1X , 2 X, 4 X and 
8 X respectively. 
c) Complement (C') : the commercial product 
(Kyokuto Phama Co.) was used for comple-
ment which corresponds to 150 to 180 CH50/ 
ml and diluted with cooled KGVB to 1 X, 2 X 
and 4 X respectively. 
d) cytotoxic assay : A mixture containing 0.2 
ml of 2 X 106 target cells, 0.5 ml of dilute anti-
serum and 0.2 ml of GPC' (3x dillution) were 
stirred at 37°C for 30 min, centrifuged at 600 
rpm for 30 min and discarded a supernatant and 
suspended with KGVB added 1 % tryphn-blue 
and the cells were harvested within three min, 
calculating a rate of staining cells. 
 Over 20% of staining rate were excluded from
this study on account of the mechanical dam-
age to the cells. 
preliminary study on cytotoxic assay 
Target cells : The relationship between target 
cells and the degree of cell damage was evalu-
ated. Under the condition of the use of three 
times dilute complement and antiserum (L & 
N2), the greatest damage was obtained in using 
2 X 106 target cells. In 5 X 106 target cells, the 
cytotoxic effect was reduced and also when an-
tiserum was diluted by over 2 X, the cytotoxic 
effect was depressed regardless of the number 
of target cells as generally called "prozone". 
Complement dosis : The cytotoxic effect was 
evaluated in relation to the dosis of comple-
ment on the same condition of target cells. On 
condition of antiserum (N1) at the 7th and 11-
th day and 2 X 106 target cells dilute comple-
ment was used as being 1 X, 2 X, 4 X, 8 X, 16 X 
and 32X. The most properly cytotoxic effects 
required a dilution of over 4 X. Above prelimi-
nary study indicated that an adequate condition 
to get the results of the cytotoxic assay. 0-
type blood is needed for using 2 X 106 target 
cells, dilute complement to 2 X 4 X, dilute 
antiserum to 2 X -16X (5 X 106/ml) 
Immune adherence hemoagglutinin test (IAMA) 
 
: The target cells were prepared according to 
the same manner as CA test. Antiserum was 
diluted with glucose-KGVB to 5 X, 10 X, 20 X, 
40 X, 80 X, and 160 X. Complement also was di-
luted with KGVB'~`to 25 X, absorbed three times 
with O-type human and dog' erythrocyte at 0 
°C 
and centrifuged at 20000 rpm for 30 min. 
The complement titer reaches a level of 150-
180 CH50/ml. The O-type human erythrocyte 
was prepared after taking from O-type human 
who was tested to be highly sensitive to the IA 
response, mixing it with equal volume of 
Alserva-solution, centrifuging three times at 
800 rpm for 10 min at 0°C and adjusting to 4 X 
108/ml with EDTA-glucose solution. 
  0.5 ml of dilute donor antiserum was mixed 
with 0.2 ml of 5 X 106 target cells, and shaked 
at 37°C for 20 min. A solution of 0.2 ml of 25 
 X GPC reabsorbed by human 0-type and dog's 
erythrocyte was standed at 37°C for 20 min and 
0.1 ml of 4 X 106 human O-type erythrocyte was 
quickly added and shaked for 10 min, standed
at 37°C warm bath for 60 min. Erythrocyte ag-
glutination at the bottom of each tubes was 
graded. After taking part of the precipitate on 
the slide glass, adherence of one or two eryth-
rocytes to lymphocytes was microscopically 
counted as to positive and calculated as per-
cent of total lymphocytes. The higher IA titer 
was shown in using antiserum at a high con-
centration of over 20X. 
          RESULTS 
Changes in humoral and cell-bound antibody 
levels following lung homotransplantation 
 Changes in the level of humoral antibody 
after lung homotransplantation was measured 
in six dogs as shown in Fig. 1 and 2. The long-
est survival was 32 days. CA varried with 21-
39% on day three, although IA was 20^-38%, 
indicating the same level as the control. There-
after, the CA levels gradually increased to 22 
^-50% on day five , 20-70% on day seven, and
Fig. 1. Humoral Antibody Response After lung 
 Allotransplantation
Fig. 2. Humoral Antibody Rlsponse After Re-
 nal Allotransplantation
20^77% on day 10. On the other hand, the IA 
values showed 30^-50% on day five, 25^-55% 
on day seven and 38^-60% on day 10 with slow 
increase. 
 In those who survive long, the level of humo-
ral antibody was not raised and there was no-
thing aware of rejection episode. At the time of 
rejection, it was generally seen that humoral 
antibody levels was increased. As a rule, the 
high levels of humoral antibody was observed 
on day five to 10. However, even in long survi-
vor of a 3 2 day duration, the humoral anti-
body levels at death was abruptly raised to 81 
% of CA. 
Changes in humoral and cell-bound antibody 
levels following kidney homotransplantation 
 The survival time of renal transplantation 
was much better than that of lung and pro-
longed to 30 days or more with satisfactory 
urine output. 
  The CA values prior to transplantation var-
ied from 10 to 18%. The humoral antibody 
levels of CA following renal transplantation 
were changed to 25^'32% on day 4^-5 and 30^-
62% on day seven without significant increase. 
However, the function-loss represented by a 
symptom of oliguria brought high level of 
humoral antibody which was 80-84% on day 
nine, 60-88% on day 10^-13 and thereafter 
reached 81-94%. 
 Changes in the IA titers also showed a simi-
lar tendency toward an increse to 25^32% on 
day five, 30-62% on day seven, 43-63% on 
day 9^,10 and 5672% on day 10-13. However, 
there was no accelerated increase in IA titer as 
seen in CA. However, it takes into consideration 
that cell-bound antibody levels were not neces-
sarily showed as it was on account of antiserum 
derived from a different recipient on the same 
condition for fear of surgical risk to take 
nodes through the surgical insult of thoraco-
tomy and laparotomy. 
  Following lung transplantation and renal 
transplantation, the humoral and cell bound 
antibody levels were compared with elapsing 
time and with antisera originated from the 
lymph nodes that were taken from the diffe-
rent sites of the pulmonary hilum (regional ) 
and the mesenterium (distant) as shown in Fig.
3 and 4. As a result it was indicated that at 
lung transplantation, the humoral antibody 
levels measured by IAMA was still more effect 
ive in knowing rejection phenomenon than those
Cell-bound Antibody Response After Renal 
Allotransplantation Following Skin Grafting
A Comparison of Humoral and Cell-bound 
Antibody Response After Renal Allotrans-
plantation
Fig. 4
done by CA, on the other hand at renal trans-
plantation the cell-bound antibody levels mea-
sured by CA were much more sensitive to ap-
pearance of rejection phenomenon rather than 
those by IA. 
Changes in humoral antibody levels at sequen-
tial lung or kidney transplantation to skin 
  In nine dogs, skin grafts were transplanted 
three times at intervals of 'one week, five of 
the nine dogs received skin grafts from identi-
cal donor but the other four had from differ-
ent donors. 
 The humoral antibody levels were gradually 
raised as being 22% (12-.28) by CA and 31 % 
(23^-40) by IA on day seven of the first skin 
transplantation, 30% (22^-38) by CA and 37% 
(33-46) by IA on day seven of the second skin 
transplantation, finally 37% (28^-45) by CA 
and 43% (.34^-56) by IA on day seven of the 
third skin transplantation. In the three dogs 
who survived more than three days following 
additional lung transplantation, the humoral 
antibody levels were raised to 69% by CA and 
65% by IA on day seven to nine. Thereafter, 
those were rapidly increased more and more. 
On day 11, all died with high humoral antibody 
level. Meanwhile, renal transplantation after 
performing skin transplantation three times 
made the humoral antibody levels still more 
increase rather than renal transplantation 
alone, that is. 63% (50^-83) by CA, 56% (49-
61) by IA on day four, 88% (84-v92) by CA,
Cell-bound Antibody Response After Lung 
Allotransplantation Following Skin Grafting
Fig. 5
A Comparison of Humoral and Cell-bound Anti-
body Response After Lung Allotrans plantation
                  Fig. 6 
73% (66^-82) by IA on day 11 and 76 (70^-81; 
by CA 62 (61^63) by IA on day 16.
Changes in cell-bound antibody levels at sequen-
tial lung or kidney transplantation to skin 
 Prior to lung or kidney transplantation, skin 
grafts were transplanted three times. In such 
a situation, the cell-bound antibody levels were 
compared between lung and kidney transplanta-
tions. The regional and mesenterial lymphnodes 
that was necessary for measurement of cell-
bound antibody were taken at the sacrifice or 
immediately before death. At lung transplanta-
tion, five dogs died on day five, two dogs on 
day seven, two, on day eight, one on day 10 
and the other one on day 3 2. The antibody 
titers of the regional lymph nodes were 52% 
(37-70) by CA, 53% (41^54) by IA and those 
of the mesenterial one 46% (32^-64) by CA 
and 47% (41-54) by IA respectively. (Fig. 7) 
 At kidney transplantation sequent to three 
times skin transplantation, the longest survival 
time was 31 days, next to 21 days and 11 days 
in two dogs. The cell-bound antibody in the re-
gional lymph nodes levels were 50% (22-70)
Fig. 7. Humoral Antibody Response After Lung Allo-
  transplantation Following Skin Grafting
Fig. 8. Humoral Antibody Response After Renal Allo-
  transplantation Following Skin Grafting
by CA, 53% (40-68) by IA and those in the 
mesenterial lymph nodes 37% (22^-45) by CA, 
33% (25^-57) by IA respectively. (Fig. 8) 
Changes in humoral antibody levels by using 
ALS 
 Following lung tranplantation, ALS was used 
for immunosuppression, and changes in humo-
ral antibody levels were compared to clarify 
the drug effects. In one of the four dogs the 
humoral antibody level measured by CA step-
weise increased and continued to die on day 15. 
However, in the other three dogs those either
by CA or IA remained almost constant through-
out observation, demonstrating the efficacy of 
the drug administrered as shown in Fig. 9. 
        DISCUSSION 
 A high prevalence of cardiac and renal trans-
plantation in clinical use has been demon-
strated in the United Stated of America and 
Europe. However, there is some problem as to 
lung transplantation with unsatisfactory out-
come experienced all over the world despite get-
ting improved results recently 8) Much has been
Fig. 7 Humoral Antibody Response After Lung Allo-
 transplantation Following Skin Grafting
reported that it is mainly -based on poor heal-
ing of bronchial anastomosis, due to interrup-
tion of bronchial artery, function deterioration 
of a donor lung due to denervation and strong 
immunologic antigenicity to allografts. In the 
host that underwent renal transplantation, con-
comitant pulmonary lesions analogous to auto-
immune diseases did not so frequently break 
out as reported by Ripkind in 19 6 4 and by 
Humburg in 1965. 
 It is suggested that anti-renal antibody may 
cross-react to the lung which is quite sensitive 
to immune reaction. 
 As compared between renal and lung trans-
plantation, the humoral antibody titers were 
raised in accordance with advances in rejection 
response with a maximum of a rise immediately 
before their deaths. 
 However, it was characteristic in that reject-
ion causes their death in lung transplantation 
although it does not so in renal transplantation. 
It implies that rejection of a donor lung at 
lung transplantation leads to death, in con-
trast, rejection of a donor kidney at renal trans-
plantation is not necessarily a sign of death. 
 It is generally accepted that cellular immuni-
ty plays an important role in falling a donor 
organ into the loss of function by rejection. 
 In the present study, the cell-bound antibody 
levels were measured with time following lung 
or kidney transplantations. Those after lung 
transplantation were not necessarily high rath-
er than those after renal transplantation. 
  However, in appearing rejection phenomen, 
the humoral antibody levels measured by IA 
was much more sensitive to knowing a dispar-
ity to foresee the rejection rather than those 
measured by CA. Of interest is the fact that on 
the contrary at renal transplantation this fact 
was reversed. It is suggested that not only cell-
ular antibody but humoral one is influential on 
the rejection response of a donor organ. 
 Preceding skin transplantation to lung or kid-
ney transplantations made the humoral anti-
body levels higher. It is indicated that the skin 
has a common antigenicity to the lung and the 
kidney. HARDY 9) reported that a recipient sen-
sitized by lung tissues of a donor accelerates a 
rejection phenomenon to subsequent skin grafts. 
 Other reports 10) 11) clarified that pretreat-
ment by lung homogenate helped get long sur-
vivors after heart transplantation in guina pig 
and lung lobe in dog by making a state of im-
munologic enhancement. Little has been avail-
able on the subject of cell-bound antibody re-
garding organ transplantation. In this study 
cell-bound antibody was detected from the sam-
ples of the regional and mesenterial nodes. On 
day five, seven and 10 following lung trans-
plantation, cell-bound antibody levels in the 
hilar and mesenterial nodes were measured by 
CA and IA. methods. The values did not varied 
except for prior to death. FuJIML! A 13) pointed 
out that r G and r G immuno-globulin positive
cells exist much more densely in the nodes of 
tracheal bifurcation rather than the mesenter-
im. At appearing a rejection of a donor lung 
these were intensified in the spleen and the lym-
ph nodes. 
 On the othe hand, KITANIURA 12) reported that 
cytotoxic activity against the cells derived 
from the cervical and axillar nodes of the 
recipient with renal transplantation was 
increased to 36-46% on day five, thereafter 
declined to 3% on day 16. 
 Very little information is available in under-
standing the mechanism of cellular immunity 
on the organ transplantation. 13) - 16) A few 
reports confirmed that immunocompetent cells 
were liberated in the blood stream of the reci-
pient and attached a donor graft specifically, 
sticking to the surface of the cell membrane 
which is part of composing graft, and not 
specifically exerting as a cytotoxic action. 
  ALS 17) 18) as a immunosuppressant was of 
benefit in reducing the humoral antibody levels. 
However, it was ineffective in some cases to 
suppress the allograft rejection response. It is 
our conviction that the humoral antibody level 
is the most valuable parameter to know the 
effectiveness of ALS on immunosuppression. 
         REFERENCE 
 1) METRAS, H : Preliminary report of total lung 
   grafts in the dog. Compt. Rend. Acad. Sci. 
   231 : 1176, 1950. 
 2) DAVrs, H.A : Homologous transplantation of 
   the lung. Arch. Surg. 64 : 745, 1952. 
 3) LANARr A, et al.: Autotransplants of the lung 
   in dogs. Medicina 15 : 83, 1955. 
 4) HAru)vN C. A : Common antigenecity between 
   skin grafts and total lung transplants. Surg. 
   Forum. 7 : 565, 1956. 
 5) KAr-Lc, DR., WrLsoN, WS., TALBERT H and 
   SLOAN, H : Response of the reimplanted lung 
   to hypoxia. Ann. Thor. Surg., 1 : 97, 1965. 
 6) NIGRO SL, Ev.,LVs RH, GAGO 0 and ADAM WE : 
   Altered physiology of the pulmonary vascu-
   lar bed a factor in decreased function of the 
   reimplanted lung. Dis. Chest 317 : 64, 1964.
 7) HAGLIN, J., TELANDCR L, Muzzall, RE, KISER
   JC and STROBEL, CJ : Comparison of lung 
   autotransplantation the primate and dog. 
   Surg. Forum 14 : 199, 1963. 
8) FRANK JV and SPENCER KK : The present status 
   of lung transplantation. Arch. Surg. 109: 734, 
  1974. 
9) HARDIN CA and WI;RDI:R AA : Effect of skin ex-
   tracts on the viability of homologous skin 
   graft in mice. Ann. N. Y. Acad. Sci. 59 : 381, 
  1955. 
10) VAN ROOD JJ, Dr VI1n s RRP, BRADLEY BA 
   Generics and Biology of the HLA system. In 
   the Role of the Major Histocompatibility 
   Complex in Immunobiology. Dorf ME (Ed) 
   New York : Garland Publishing Co. 59-113, 
   1981. 
11) CARDCI.LA CJ, FALK JA, Pi:rl rzs P, Niciioi.soN J, 
   HARTxNG M. Do repeated blood transfusion 
   prevent successful transplantation in highly 
   sensitized potential transplant recipients ? 
   Transplant Proc. 11 :1889, 1982. 
12) KrrAMuRA S : Effect of immunological enhan-
   cement by lung tissue homogenate on skin 
   allografts. Jap. J. transplantation 3 : 36, 1968 
   (in Japanlse). 
13) SANFILIPPo F, VAUGII:. WK, SPECS EK, LIGI IT JA, 
   LEFOR WM. Benefits HLA-A and HLA-B 
   matching on graft and patient outcome after 
   cadaveric-donor renal transplantation. New 
   England Journal of Medicine 311: 358, 1984. 
14) PERSMN GG, COHEN B, LANSBERG EN Q, D'AMMANO 
   J, SCLwECD N, WING A, VAN Roo I) JJ : Effect of 
   HLA-A and HLA-B matching on graft and
   patient outcome after cadaveric-donor renal 
   transplantation. New England Journal of 
   Medicine 311 : 358, 1984. 
15) CARDELLA CJ, FALK JA, NICtIOI.SON MJ, HARDING 
   M, Cooic GT : Successful renal transplantation 
   in patients with T-cell reactivity to donor. 
   Lancet 2 : 1240, 1982. 
16) MORRIS PJ : Immunosuppression in renal 
   transplantation. Transplant. Pro c. 18 : 1158, 
  1986. 
17) MONACO AP. : Antilymphocyte globulin : A 
   clinical transplantation research opportunity. 
   Am J. Kidney Dis 2 : 67, 1982. 
18) CI-ro SI, BRADLEY JW, Costmi AB, MONACO Ao, 
   NAI3sITi-i DC : Pretransplant blood trans-
   fusions in ALG treated cadaver kidney reci-
   pients. Transplant. Proc. 15 : 962, 1983.
